Lupus Forum
Sign in   Register
  • Home
  • Publications
  • Podcasts
  • Congresses
  • Educational Videos
  • Therapies
  • Resources
  • Lupus Live
  • Contact

Publications

All ▼
(Checked) All
Date of upload ▼
(Checked) Date of upload Date of publication Published 2025 Published 2024 Published 2023 Published 2022 Published 2021

Find coverage of the latest original articles on Lupus, focusing on those with data on therapeutic interventions and those that have clinical impact.

Literature Highlights

Literature review thumbnail: Literature Highlights - April 2025
View Slides

Literature Highlights - April 2025

more…

Keywords:

Autoimmunity, Belimumab, B cells, immune cells, IPTW, LLDAS, machine learning, single cell RNA sequencing, Systemic lupus erythematosus, Telitacicept.
Previous

Publications

Clear Search

Showing 1 result for “García de Yébenes MJ”.

May 2024
Publication thumbnail: SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort View Slides

SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort

Rua-Figueroa I
,
García de Yébenes MJ
,
Martinez-Barrio J
,
Galindo Izquierdo M
,
Calvo Alén J
,
Fernandez-Nebro A
,
Menor-Almagro R
,
Carmona L
,
Tejera Segura B
,
Tomero E
,
Freire-González M
,
Sangüesa C
,
Horcada L
,
Blanco R
,
Uriarte Itzazelaia E
,
Narváez J
,
Rosas Gómez de Salazar JC
,
Gómez-Sabater S
,
Morales CM
,
Andreu JL
,
Segarra VT
,
Aurrecoechea E
,
Perez A
,
Nóvoa Medina J
,
Salgado E
,
Lozano-Rivas N
,
Montilla C
,
Ruiz-Lucea E
,
Arevalo M
,
Iñiguez C
,
García-Villanueva MJ
,
Exposito L
,
Ibáñez-Barceló M
,
Bonilla G
,
Carrión-Barberà I
,
Erausquin C
,
Fragio Gil JJ
,
Pecondón A
,
Toyos FJ
,
Cobo T
,
Muñoz-Jiménez A
,
Oller J
,
Nolla JM
,
Pego-Reigosa JM

Lupus Sci Med. 2024; 11(1): e001096 DOI: 10.1136/lupus-2023-001096

SLESIS-R may help clinicians make informed decisions on the occurrence of a serious infection in the following year in SLE from four variables: age ≥60 years, previous admission for SLE, previous infection and having received a maximum dose of glucocorticoids ≥30 mg.

more…

Keywords:

  • epidemiology,
  • lupus erythematosus,
  • systemic,
  • risk factors
Download Slides Access via PubMed
 
All Sponsor Logos AstraZeneca GSK Abbvie Bristol Myers Squibb Novartis Otsuka Roche Biogen Aurinia UCB Merck

Developed under the auspices of:

University of Leeds

Follow us on:

X LinkedIn Apple Podcasts
APEX Award Winning logo
Health Awards logo
© 2014 - 2025 | Supported by CESAS Medical.    Legal | Contact | Site Map